SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-010029
Filing Date
2019-05-15
Accepted
2019-05-15 15:03:12
Documents
92
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nby20190331_10q.htm 10-Q 1239356
2 EXHIBIT 31.1 ex_143273.htm EX-31.1 8595
3 EXHIBIT 31.2 ex_143274.htm EX-31.2 8673
4 EXHIBIT 32.1 ex_143275.htm EX-32.1 4395
5 EXHIBIT 32.2 ex_143276.htm EX-32.2 4308
  Complete submission text file 0001437749-19-010029.txt   7905974

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nby-20190331.xml EX-101.INS 1639882
7 XBRL TAXONOMY EXTENSION SCHEMA nby-20190331.xsd EX-101.SCH 98884
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nby-20190331_cal.xml EX-101.CAL 56220
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20190331_def.xml EX-101.DEF 608407
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20190331_lab.xml EX-101.LAB 512827
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20190331_pre.xml EX-101.PRE 648163
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 19827412
SIC: 2834 Pharmaceutical Preparations